Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McDonnell

Showing results (331-340 of 374) with videos related to

Pageof 38
Sort By:
Molecular Cancer Research : MCR|February 18, 2017
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPCJames P Stice, Suzanne E Wardell, John D Norris, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironmentBinita Chakraborty, Prabuddha Chakraborty, Michael C Brown, et al.
Autophagy|February 12, 2025
ESRRA (estrogen related receptor, alpha) induces ribosomal protein RPLP1-mediated adaptive hepatic translation during prolonged starvationMadhulika Tripathi, Karine Gauthier, Reddemma Sandireddy, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
The Journal of Clinical Investigation|October 12, 2021
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanomaBinita Chakraborty, Jovita Byemerwa, Jonathan Shepherd, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Nature Communications|October 13, 2017
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cellsAmy E Baek, Yen-Rei A Yu, Sisi He, et al.
Blood|July 2, 2013
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphomaScott R P McDonnell, Steven R Hwang, Delphine Rolland, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Mitoxantrone inhibits and downregulates ER <i>α</i> through binding at the DBD-LBD interfaceHan Wang, Yuxuan Luo, Sandeep Artham, et al.
Pageof 38

Showing results (331-340 of 374) with videos related to

Sort By:
Pageof 38
Molecular Cancer Research : MCR|February 18, 2017
CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPCJames P Stice, Suzanne E Wardell, John D Norris, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironmentBinita Chakraborty, Prabuddha Chakraborty, Michael C Brown, et al.
Autophagy|February 12, 2025
ESRRA (estrogen related receptor, alpha) induces ribosomal protein RPLP1-mediated adaptive hepatic translation during prolonged starvationMadhulika Tripathi, Karine Gauthier, Reddemma Sandireddy, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
The Journal of Clinical Investigation|October 12, 2021
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanomaBinita Chakraborty, Jovita Byemerwa, Jonathan Shepherd, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Nature Communications|October 13, 2017
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cellsAmy E Baek, Yen-Rei A Yu, Sisi He, et al.
Blood|July 2, 2013
Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphomaScott R P McDonnell, Steven R Hwang, Delphine Rolland, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Mitoxantrone inhibits and downregulates ER <i>α</i> through binding at the DBD-LBD interfaceHan Wang, Yuxuan Luo, Sandeep Artham, et al.
Pageof 38